Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 3
2004 3
2005 6
2006 4
2007 3
2008 6
2009 7
2010 9
2011 9
2012 13
2013 15
2014 14
2015 15
2016 12
2017 13
2018 12
2019 13
2020 21
2021 22
2022 24
2023 24
2024 15
2025 5

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

239 results

Results by year

Filters applied: . Clear all
Page 1
Phase III, Randomized Study of Atezolizumab Plus Bevacizumab and Chemotherapy in Patients With EGFR- or ALK-Mutated Non-Small-Cell Lung Cancer (ATTLAS, KCSG-LU19-04).
Park S, Kim TM, Han JY, Lee GW, Shim BY, Lee YG, Kim SW, Kim IH, Lee S, Kim YJ, Park JH, Park SG, Lee KH, Kang EJ, Kim JW, Shin SH, Ock CY, Nam BH, Lee J, Jung HA, Sun JM, Lee SH, Ahn JS, Ahn MJ. Park S, et al. Among authors: kim ih. J Clin Oncol. 2024 Apr 10;42(11):1241-1251. doi: 10.1200/JCO.23.01891. Epub 2023 Oct 20. J Clin Oncol. 2024. PMID: 37861993 Free PMC article. Clinical Trial.
Integrative analysis of risk factors for immune-related adverse events of checkpoint blockade therapy in cancer.
Sung C, An J, Lee S, Park J, Lee KS, Kim IH, Han JY, Park YH, Kim JH, Kang EJ, Hong MH, Kim TY, Lee JC, Lee JL, Yoon S, Choi CM, Lee DH, Yoo C, Kim SW, Jeong JH, Seo S, Kim SY, Kong SY, Choi JK, Park SR. Sung C, et al. Among authors: kim ih. Nat Cancer. 2023 Jun;4(6):844-859. doi: 10.1038/s43018-023-00572-5. Epub 2023 Jun 12. Nat Cancer. 2023. PMID: 37308678
Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer: A large real-life worldwide population.
Rimini M, Fornaro L, Rizzato MD, Antonuzzo L, Rossari F, Satake T, Vandeputte H, Vivaldi C, Pressiani T, Lucchetti J, Kim JW, Abidoye O, Rapposelli IG, Tamberi S, Finkelmeier F, Giordano G, Nichetti F, Chon HJ, Braconi C, Pirrone C, Castet F, Tamburini E, Yoo C, Parisi A, Diana A, Scartozzi M, Prager GW, Avallone A, Schirripa M, Kim IH, Perkhofer L, Oneda E, Verrico M, Adeva J, Chan SL, Spinelli GP, Personeni N, Garajova I, Rodriquenz MG, Leo S, Salani F, De Rosa A, Lavacchi D, Foti S, Ikeda M, Dekervel J, Niger M, Balsano R, Tonini G, Kang M, Bekaii-Saab T, Esposito L, Boccaccino A, Himmelsbach V, Landriscina M, Djaballah SA, Zanuso V, Masi G, Lonardi S, Rimassa L, Casadei-Gardini A. Rimini M, et al. Among authors: kim ih. Eur J Cancer. 2024 Sep;208:114199. doi: 10.1016/j.ejca.2024.114199. Epub 2024 Jun 30. Eur J Cancer. 2024. PMID: 39002348
Radiotherapy-induced pemphigus vulgaris.
Jang HW, Chun SH, Lee JM, Jeon J, Hashimoto T, Kim IH. Jang HW, et al. Among authors: kim ih. J Dermatol. 2014 Sep;41(9):851-2. doi: 10.1111/1346-8138.12582. Epub 2014 Aug 11. J Dermatol. 2014. PMID: 25109377 No abstract available.
Nucleic Acid Testing of SARS-CoV-2.
Yoo HM, Kim IH, Kim S. Yoo HM, et al. Among authors: kim ih. Int J Mol Sci. 2021 Jun 7;22(11):6150. doi: 10.3390/ijms22116150. Int J Mol Sci. 2021. PMID: 34200331 Free PMC article. Review.
Neurogenic rosacea in Korea.
Kim HO, Kang SY, Kim KE, Cho SY, Kim KH, Kim IH. Kim HO, et al. Among authors: kim ih. J Dermatol. 2021 Jan;48(1):49-55. doi: 10.1111/1346-8138.15629. Epub 2020 Nov 19. J Dermatol. 2021. PMID: 33211906
Fiberglass-induced granulomatous periorificial dermatitis.
Kim KE, Park TJ, Son SW, Kim IH, Moon HR. Kim KE, et al. Among authors: kim ih. J Dermatol. 2019 Sep;46(9):e334-e335. doi: 10.1111/1346-8138.14859. Epub 2019 Mar 21. J Dermatol. 2019. PMID: 30897228 No abstract available.
SARS-CoV-2 B.1.619 and B.1.620 Lineages, South Korea, 2021.
Park AK, Kim IH, Man Kim H, Lee H, Lee NJ, Kim JA, Woo S, Lee CY, Lee J, Oh SJ, Rhee J, Yoo CK, Kim EJ. Park AK, et al. Among authors: kim ih. Emerg Infect Dis. 2022 Feb;28(2):415-419. doi: 10.3201/eid2802.211653. Emerg Infect Dis. 2022. PMID: 35076365 Free PMC article.
Efficacy of cisplatin-gemcitabine-durvalumab in patients with advanced biliary tract cancer experiencing early vs late disease relapse after surgery: a large real-life worldwide population.
Lo Prinzi F, Salani F, Rimini M, Rizzato MD, Antonuzzo L, Camera S, Satake T, Vandeputte H, Vivaldi C, Pressiani T, Lucchetti J, Kim JW, Abidoye O, Rapposelli IG, Tamberi S, Finkelmeier F, Giordano G, Pircher C, Chon HJ, Braconi C, Pastorino A, Castet F, Tamburini E, Yoo C, Parisi A, Diana A, Scartozzi M, Prager GW, Avallone A, Schirripa M, Kim IH, Perkhofer L, Oneda E, Verrico M, Adeva J, Chan SL, Spinelli GP, Personeni N, Garajova I, Rodriquenz MG, Leo S, Melo Alvim C, Roque R, Fornaro L, De Rosa A, Lavacchi D, Rossari F, Ikeda M, Dekervel J, Niger M, Balsano R, Tonini G, Kang M, Bekaii-Saab T, Viola MG, Silvestro L, Esposito L, Boccaccino A, Himmelsbach V, Landriscina M, Ahcene Djaballah S, Zanuso V, Masi G, Lonardi S, Rimassa L, Casadei-Gardini A. Lo Prinzi F, et al. Among authors: kim ih. Oncologist. 2025 Mar 10;30(3):oyae256. doi: 10.1093/oncolo/oyae256. Oncologist. 2025. PMID: 39427227 Free PMC article.
239 results